REFG — Medical Cannabis Payment Solutions Income Statement
0.000.00%
IndustrialsHighly SpeculativeMicro Cap
- $0.06m
- $0.20m
Annual income statement for Medical Cannabis Payment Solutions, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2007 December 31st | 2008 December 31st | 2010 December 31st | 2011 December 31st | 2012 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PRESS | ARS | PRESS | PRESS | PRESS |
Standards: | — | — | — | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.84 | 1.54 | 0 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | 1.6 | -0.04 | — | — | — |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 13.1 | 4.11 | 0.134 | 0.029 | 0.108 |
Operating Profit | -9.25 | -2.57 | -0.134 | -0.029 | -0.108 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -9.28 | -3.4 | -2.93 | -0.029 | -0.114 |
Provision for Income Taxes | |||||
Net Income After Taxes | -9.28 | -3.4 | -2.93 | -0.029 | -0.114 |
Net Income Before Extraordinary Items | |||||
Net Income | -9.28 | -3.4 | -2.93 | -0.029 | -0.114 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -9.28 | -3.4 | -2.93 | -0.029 | -0.114 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.158 | -0.047 | -0.009 | -0 | -0 |
Dividends per Share |